{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:43:26Z","timestamp":1791557006179,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Health Research Foundation of Central Denmark Region"},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF19OC0058872"],"award-info":[{"award-number":["NNF19OC0058872"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF22OC0081911"],"award-info":[{"award-number":["NNF22OC0081911"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","award":["Jr. No. 23-10-0145"],"award-info":[{"award-number":["Jr. No. 23-10-0145"]}],"id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00125-025-06614-0","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T19:58:49Z","timestamp":1764359929000},"page":"752-763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ketone supplementation dose-dependently lowers postprandial blood glucose, lipid and ghrelin levels in individuals with type 2 diabetes: a randomised crossover study"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6265-2854","authenticated-orcid":false,"given":"Maj","family":"Bangshaab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8985-8385","authenticated-orcid":false,"given":"Mads B.","family":"Bengtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0225-8809","authenticated-orcid":false,"given":"Stine","family":"Smedegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8041-6994","authenticated-orcid":false,"given":"Esben","family":"S\u00f8ndergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5627-7322","authenticated-orcid":false,"given":"Niels","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9574-0612","authenticated-orcid":false,"given":"Mads V.","family":"Svart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9938-2181","authenticated-orcid":false,"given":"Nikolaj","family":"Rittig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"1","key":"6614_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/diabetes.54.1.1","volume":"54","author":"A Ceriello","year":"2005","unstructured":"Ceriello A (2005) Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 54(1):1\u20137. https:\/\/doi.org\/10.2337\/diabetes.54.1.1","journal-title":"Diabetes"},{"issue":"4","key":"6614_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jjcc.2015.12.001","volume":"67","author":"K Nakamura","year":"2016","unstructured":"Nakamura K, Miyoshi T, Yunoki K, Ito H (2016) Postprandial hyperlipidemia as a potential residual risk factor. J Cardiol 67(4):335\u2013339. https:\/\/doi.org\/10.1016\/j.jjcc.2015.12.001","journal-title":"J Cardiol"},{"key":"6614_CR3","doi-asserted-by":"publisher","unstructured":"Traugott K (1922) \u00fcber das Verhalten des Blutzuckerspiegels bei Wiederholter und Verschiedener Art Enteraler Zuckerzufuhr und Dessen Bedeutung f\u00fcr die Leberfunktion. Klinische Wochenschrift 1(18):892\u2013894 [article in German]. https:\/\/doi.org\/10.1007\/BF01715866","DOI":"10.1007\/BF01715866"},{"issue":"2","key":"6614_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ajcnut.2023.05.012","volume":"118","author":"S Smedegaard","year":"2023","unstructured":"Smedegaard S, Kampmann U, Ovesen PG, St\u00f8vring H, Rittig N (2023) Whey protein premeal lowers postprandial glucose concentrations in adults compared with water-the effect of timing, dose, and metabolic status: a systematic review and meta-analysis. Am J Clin Nutr 118(2):391\u2013405. https:\/\/doi.org\/10.1016\/j.ajcnut.2023.05.012","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"6614_CR5","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00125-024-06122-7","volume":"67","author":"AJ Monteyne","year":"2024","unstructured":"Monteyne AJ, Falkenhain K, Whelehan G et al (2024) A ketone monoester drink reduces postprandial blood glucose concentrations in adults with type 2 diabetes: a randomised controlled trial. Diabetologia 67(6):1107\u20131113. https:\/\/doi.org\/10.1007\/s00125-024-06122-7","journal-title":"Diabetologia"},{"issue":"20","key":"6614_CR6","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/circulationaha.124.069732","volume":"150","author":"N Gopalasingam","year":"2024","unstructured":"Gopalasingam N, Berg-Hansen K, Christensen KH et al (2024) Randomized crossover trial of 2-week ketone ester treatment in patients with type 2 diabetes and heart failure with preserved ejection fraction. Circulation 150(20):1570\u20131583. https:\/\/doi.org\/10.1161\/circulationaha.124.069732","journal-title":"Circulation"},{"issue":"19","key":"6614_CR7","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1161\/circulationaha.123.067971","volume":"149","author":"K Berg-Hansen","year":"2024","unstructured":"Berg-Hansen K, Gopalasingam N, Christensen KH et al (2024) Cardiovascular effects of oral ketone ester treatment in patients with heart failure with reduced ejection fraction: a randomized, controlled, double-blind trial. Circulation 149(19):1474\u20131489. https:\/\/doi.org\/10.1161\/circulationaha.123.067971","journal-title":"Circulation"},{"issue":"2","key":"6614_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1530\/eje-19-0710","volume":"182","author":"NJ Jensen","year":"2020","unstructured":"Jensen NJ, Nilsson M, Ingerslev JS et al (2020) Effects of \u03b2-hydroxybutyrate on cognition in patients with type 2 diabetes. Eur J Endocrinol 182(2):233\u2013242. https:\/\/doi.org\/10.1530\/eje-19-0710","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"6614_CR9","doi-asserted-by":"publisher","first-page":"e14385","DOI":"10.1111\/dme.14385","volume":"38","author":"M Svart","year":"2020","unstructured":"Svart M, Rittig N, Pedersen SB, Jessen N, M\u00f8ller N (2020) Oral 3-hydroxybutyrate ingestion decreases endogenous glucose production, lipolysis, and hormone-sensitive lipase phosphorylation in adipose tissue in men: a human randomized, controlled, crossover trial. Diabet Med 38(2):e14385. https:\/\/doi.org\/10.1111\/dme.14385","journal-title":"Diabet Med"},{"key":"6614_CR10","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3389\/fphys.2017.00848","volume":"8","author":"BJ Stubbs","year":"2017","unstructured":"Stubbs BJ, Cox PJ, Evans RD et al (2017) On the metabolism of exogenous ketones in humans. Front Physiol 8:848. https:\/\/doi.org\/10.3389\/fphys.2017.00848","journal-title":"Front Physiol"},{"issue":"2","key":"6614_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","volume":"25","author":"P Puchalska","year":"2017","unstructured":"Puchalska P, Crawford PA (2017) Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab 25(2):262\u2013284. https:\/\/doi.org\/10.1016\/j.cmet.2016.12.022","journal-title":"Cell Metab"},{"issue":"9","key":"6614_CR12","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1210\/clinem\/dgaa370","volume":"105","author":"N M\u00f8ller","year":"2020","unstructured":"M\u00f8ller N (2020) Ketone body, 3-hydroxybutyrate: minor metabolite - major medical manifestations. J Clin Endocrinol Metab 105(9):2884\u20132892. https:\/\/doi.org\/10.1210\/clinem\/dgaa370","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"6614_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/advances\/nmaa130","volume":"12","author":"PL Valenzuela","year":"2021","unstructured":"Valenzuela PL, Castillo-Garc\u00eda A, Morales JS, Lucia A (2021) Perspective: ketone supplementation in sports-does it work? Adv Nutr 12(2):305\u2013315. https:\/\/doi.org\/10.1093\/advances\/nmaa130","journal-title":"Adv Nutr"},{"issue":"5","key":"6614_CR14","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1093\/advances\/nmac036","volume":"13","author":"K Falkenhain","year":"2022","unstructured":"Falkenhain K, Daraei A, Forbes SC, Little JP (2022) Effects of exogenous ketone supplementation on blood glucose: a systematic review and meta-analysis. Adv Nutr 13(5):1697\u20131714. https:\/\/doi.org\/10.1093\/advances\/nmac036","journal-title":"Adv Nutr"},{"issue":"1","key":"6614_CR15","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s41467-021-21235-y","volume":"12","author":"FA Duca","year":"2021","unstructured":"Duca FA, Waise TMZ, Peppler WT, Lam TKT (2021) The metabolic impact of small intestinal nutrient sensing. Nat Commun 12(1):903. https:\/\/doi.org\/10.1038\/s41467-021-21235-y","journal-title":"Nat Commun"},{"issue":"10","key":"6614_CR16","doi-asserted-by":"publisher","first-page":"dgaa483","DOI":"10.1210\/clinem\/dgaa483","volume":"105","author":"N Rittig","year":"2020","unstructured":"Rittig N, Svart M, Thomsen HH et al (2020) Oral D\/L-3-hydroxybutyrate stimulates cholecystokinin- and insulin secretion and slows gastric emptying in healthy males. J Clin Endocrinol Metab 105(10):dgaa483. https:\/\/doi.org\/10.1210\/clinem\/dgaa483","journal-title":"J Clin Endocrinol Metab"},{"issue":"29","key":"6614_CR17","doi-asserted-by":"publisher","first-page":"26649","DOI":"10.1074\/jbc.C500213200","volume":"280","author":"AK Taggart","year":"2005","unstructured":"Taggart AK, Kero J, Gan X et al (2005) (D)-\u03b2-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem 280(29):26649\u201326652. https:\/\/doi.org\/10.1074\/jbc.C500213200","journal-title":"J Biol Chem"},{"issue":"2","key":"6614_CR18","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1210\/jc.2014-2608","volume":"100","author":"KH Mikkelsen","year":"2015","unstructured":"Mikkelsen KH, Seifert T, Secher NH, Gr\u00f8ndal T, van Hall G (2015) Systemic, cerebral and skeletal muscle ketone body and energy metabolism during acute hyper-D-\u03b2-hydroxybutyratemia in post-absorptive healthy males. J Clin Endocrinol Metab 100(2):636\u2013643. https:\/\/doi.org\/10.1210\/jc.2014-2608","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"6614_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/oby.22051","volume":"26","author":"BJ Stubbs","year":"2018","unstructured":"Stubbs BJ, Cox PJ, Evans RD, Cyranka M, Clarke K, de Wet H (2018) A ketone ester drink lowers human ghrelin and appetite. Obesity (Silver Spring) 26(2):269\u2013273. https:\/\/doi.org\/10.1002\/oby.22051","journal-title":"Obesity (Silver Spring)"},{"issue":"8","key":"6614_CR20","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1111\/dom.14402","volume":"23","author":"ET Vestergaard","year":"2021","unstructured":"Vestergaard ET, Zubanovic NB, Rittig N et al (2021) Acute ketosis inhibits appetite and decreases plasma concentrations of acyl ghrelin in healthy young men. Diabetes Obes Metab 23(8):1834\u20131842. https:\/\/doi.org\/10.1111\/dom.14402","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"6614_CR21","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1113\/jp275709","volume":"596","author":"\u00c9 Myette-C\u00f4t\u00e9","year":"2018","unstructured":"Myette-C\u00f4t\u00e9 \u00c9, Neudorf H, Rafiei H, Clarke K, Little JP (2018) Prior ingestion of exogenous ketone monoester attenuates the glycaemic response to an oral glucose tolerance test in healthy young individuals. J Physiol 596(8):1385\u20131395. https:\/\/doi.org\/10.1113\/jp275709","journal-title":"J Physiol"},{"issue":"5","key":"6614_CR22","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/jdi.13423","volume":"12","author":"T Nakagata","year":"2021","unstructured":"Nakagata T, Tamura Y, Kaga H et al (2021) Ingestion of an exogenous ketone monoester improves the glycemic response during oral glucose tolerance test in individuals with impaired glucose tolerance: a cross-over randomized trial. J Diabetes Investig 12(5):756\u2013762. https:\/\/doi.org\/10.1111\/jdi.13423","journal-title":"J Diabetes Investig"},{"issue":"1","key":"6614_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2337\/cd24-0003","volume":"43","author":"V Melenovsk\u00fd","year":"2024","unstructured":"Melenovsk\u00fd V, Ho\u0161kov\u00e1 E, Velebov\u00e1 K et al (2024) Metformin improves glycemic control and postprandial metabolism and enhances postprandial glucagon-like peptide 1 secretion in patients with type 2 diabetes and heart failure: a randomized, double-blind, placebo-controlled trial. Clini Diabetes 43(1):23\u201332. https:\/\/doi.org\/10.2337\/cd24-0003","journal-title":"Clini Diabetes"},{"issue":"7","key":"6614_CR24","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1007\/s00125-024-06131-6","volume":"67","author":"C Xie","year":"2024","unstructured":"Xie C, Iroga P, Bound MJ et al (2024) Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study. Diabetologia 67(7):1260\u20131270. https:\/\/doi.org\/10.1007\/s00125-024-06131-6","journal-title":"Diabetologia"},{"issue":"9","key":"6614_CR25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1056\/nejm199508313330902","volume":"333","author":"RA DeFronzo","year":"1995","unstructured":"DeFronzo RA, Goodman AM (1995) Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med 333(9):541\u2013549. https:\/\/doi.org\/10.1056\/nejm199508313330902","journal-title":"N Engl J Med"},{"issue":"12","key":"6614_CR26","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.2337\/dc06-0703","volume":"29","author":"P Aschner","year":"2006","unstructured":"Aschner P, Kipnes MS, Lunceford JK et al (2006) Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care 29(12):2632\u20132637. https:\/\/doi.org\/10.2337\/dc06-0703","journal-title":"Diabetes Care"},{"issue":"1","key":"6614_CR27","doi-asserted-by":"publisher","first-page":"E61","DOI":"10.1152\/ajpendo.00332.2023","volume":"326","author":"K Falkenhain","year":"2024","unstructured":"Falkenhain K, Oliveira BF, Islam H et al (2024) The effect of acute and 14-day exogenous ketone supplementation on glycemic control in adults with type 2 diabetes: two randomized controlled trials. Am J Physiol Endocrinol Metab 326(1):E61\u2013E72. https:\/\/doi.org\/10.1152\/ajpendo.00332.2023","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6614_CR28","doi-asserted-by":"publisher","first-page":"101774","DOI":"10.1016\/j.ctcp.2023.101774","volume":"52","author":"Q Yu","year":"2023","unstructured":"Yu Q, Falkenhain K, Little JP et al (2023) Effects of ketone supplements on blood \u03b2-hydroxybutyrate, glucose and insulin: a systematic review and three-level meta-analysis. Complement Ther Clin Pract 52:101774. https:\/\/doi.org\/10.1016\/j.ctcp.2023.101774","journal-title":"Complement Ther Clin Pract"},{"issue":"1","key":"6614_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1113\/jphysiol.2008.164012","volume":"587","author":"G Tolhurst","year":"2009","unstructured":"Tolhurst G, Reimann F, Gribble FM (2009) Nutritional regulation of glucagon-like peptide-1 secretion. J Physiol 587(1):27\u201332. https:\/\/doi.org\/10.1113\/jphysiol.2008.164012","journal-title":"J Physiol"},{"issue":"2","key":"6614_CR30","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1021\/acs.jmedchem.8b01644","volume":"62","author":"C M'Kadmi","year":"2019","unstructured":"M\u2019Kadmi C, Cabral A, Barrile F et al (2019) N-terminal liver-expressed antimicrobial peptide 2 (LEAP2) region exhibits inverse agonist activity toward the ghrelin receptor. J Med Chem 62(2):965\u2013973. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01644","journal-title":"J Med Chem"},{"issue":"4","key":"6614_CR31","doi-asserted-by":"publisher","first-page":"100582","DOI":"10.1016\/j.xcrm.2022.100582","volume":"3","author":"CA Hagemann","year":"2022","unstructured":"Hagemann CA, Jensen MS, Holm S et al (2022) LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men. Cell Rep Med 3(4):100582. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100582","journal-title":"Cell Rep Med"},{"issue":"7","key":"6614_CR32","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1111\/dom.15044","volume":"25","author":"SK Holm","year":"2023","unstructured":"Holm SK, Vestergaard ET, Zubanovic NB et al (2023) Ketone monoester increases circulating levels of LEAP2 and decreases appetite in healthy men. Diabetes Obes Metab 25(7):2023\u20132027. https:\/\/doi.org\/10.1111\/dom.15044","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"6614_CR33","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.ajcnut.2023.10.007","volume":"118","author":"MGB Pedersen","year":"2023","unstructured":"Pedersen MGB, Lauritzen ES, Svart MV et al (2023) Nutrient sensing: LEAP2 concentration in response to fasting, glucose, lactate, and \u03b2-hydroxybutyrate in healthy young males. Am J Clin Nutr 118(6):1091\u20131098. https:\/\/doi.org\/10.1016\/j.ajcnut.2023.10.007","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"6614_CR34","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.yrtph.2012.04.008","volume":"63","author":"K Clarke","year":"2012","unstructured":"Clarke K, Tchabanenko K, Pawlosky R et al (2012) Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul Toxicol Pharmacol 63(3):401\u2013408. https:\/\/doi.org\/10.1016\/j.yrtph.2012.04.008","journal-title":"Regul Toxicol Pharmacol"},{"issue":"3","key":"6614_CR35","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1208\/s12248-016-9879-0","volume":"18","author":"V Shivva","year":"2016","unstructured":"Shivva V, Cox PJ, Clarke K, Veech RL, Tucker IG, Duffull SB (2016) The population pharmacokinetics of d-\u03b2-hydroxybutyrate following administration of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate. AAPS J 18(3):678\u2013688. https:\/\/doi.org\/10.1208\/s12248-016-9879-0","journal-title":"AAPS J"},{"issue":"12","key":"6614_CR36","doi-asserted-by":"publisher","first-page":"e3974","DOI":"10.1371\/journal.pone.0003974","volume":"3","author":"CD Dotson","year":"2008","unstructured":"Dotson CD, Zhang L, Xu H et al (2008) Bitter taste receptors influence glucose homeostasis. PLoS One 3(12):e3974. https:\/\/doi.org\/10.1371\/journal.pone.0003974","journal-title":"PLoS One"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06614-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-025-06614-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06614-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T12:00:58Z","timestamp":1770379258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-025-06614-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["6614"],"URL":"https:\/\/doi.org\/10.1007\/s00125-025-06614-0","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors would like to express their sincere gratitude to all study participants for their generous contributions of time and effort. We are deeply thankful to L. Buus, E. Hornemann, M. L. Schwartz, S. Birk Wittorff, L. Mentz and E. Schriver (Medical\/Steno Aarhus Research Laboratory, Aarhus University) for their skilled technical expertise and invaluable assistance during the studies. The authors take full responsibility for the content and all statements presented in the manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}},{"value":"The data supporting this study will be made available on reasonable request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The study was supported by the Novo Nordisk Foundation (NNF19OC0058872 and NNF22OC0081911), the Health Research Foundation of Central Denmark Region and the Aase Einar Danielsen Fund (Jr. No. 23-10-0145).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"NM is the co-founder of Mmimetika Biosciences ApS, a spin-out company entitled to develop and sell a newly invented lactate\/ketone body ester. The other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"MB, MBB, NM, SS, MVS and NR conceived and designed the studies. MB, MBB and SS conducted the studies. MB and MBB analysed the data. MB, MBB, NM, ES, MVS and NR contributed to the interpretation of results. MB and MBB drafted the manuscript. MB, MBB, NM, SS, ES, MVS and NR reviewed and approved the final manuscript. NR, MVS, MB and MBB are the guarantors, accept full responsibility for the work, have access to the data and control the decision to publish.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}